Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sabbatini

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Neuroendocrinology|July 23, 2011
GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogsVivian J A Costantini, Elena Vicentini, Fabio M Sabbatini, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonistsFabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptorRomano Di Fabio, Fabrizio Micheli, Davide Baraldi, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|March 1, 1997
Gradual bone distraction in craniosynostosis. Preliminary results in seven casesC M do Amaral, G Di Domizio, V Tiziani, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Journal of Medicinal Chemistry|November 4, 2008
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studiesRomano Di Fabio, Roberto Arban, Giovanni Bernasconi, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Medicinal Chemistry|November 8, 2008
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonistsRomano Di Fabio, Yves St-Denis, Fabio M Sabbatini, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Neuroendocrinology|July 23, 2011
GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogsVivian J A Costantini, Elena Vicentini, Fabio M Sabbatini, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonistsFabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptorRomano Di Fabio, Fabrizio Micheli, Davide Baraldi, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|March 1, 1997
Gradual bone distraction in craniosynostosis. Preliminary results in seven casesC M do Amaral, G Di Domizio, V Tiziani, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Journal of Medicinal Chemistry|November 4, 2008
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studiesRomano Di Fabio, Roberto Arban, Giovanni Bernasconi, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Medicinal Chemistry|November 8, 2008
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonistsRomano Di Fabio, Yves St-Denis, Fabio M Sabbatini, et al.
Pageof 14